Business Standard

Sunday, December 22, 2024 | 12:55 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Immunity hurdle for a shot at Covid vaccine; govt working on priority list

Rapid antibody tests at dedicated Covid-19 vaccination centres to act as screening tool

test, coronavirus, covid
Premium

Bernstein analysts pointed out in a recent report that the Indian government is likely to procure 680 million doses. This will imply a spending of $1.9 billion

Sohini Das Mumbai
If you are eager to get a Covid-19 shot at the earliest, breathe easy. You might as well brace for a screening hurdle at dedicated vaccination sites that would identify antibodies, according to sources in the government.

India is likely to take a judicious approach in immunising its humungous population with the much-awaited vaccine for the novel coronavirus.

People who have already developed antibodies against the Sars-CoV-2 virus would not be considered for a jab, as the government does not wish to waste the precious vaccine shots.

The dedicated vaccination sites would be equipped with a facility to carry out rapid antibody tests.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in